| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Address reprint requests to: Michael J. McMahon, MD, MPH Department of Obstetrics and Gynecology University of North Carolina at Chapel Hill 214 MacNider Building, Campus Box 7570 Chapel Hill, NC 27599-7570 E-mail: mcmahon{at}med.unc.edu
Objective: To determine whether women with polycystic ovary syndrome (PCOS) are more likely to develop gestational diabetes mellitus compared with age- and weight-matched controls.
Methods: This retrospective cohort study compared reproductive-age women with and without PCOS who received prenatal care at the University of North Carolina Hospitals between April 1989 and June 1998. We reviewed the medical charts of 22 women with PCOS diagnosis before pregnancy based on menstrual histories, elevated androgen levels, and LH-FSH ratios greater than 2. These women were compared with 66 women without PCOS matched for age and weight. Gestational diabetes mellitus (GDM) was diagnosed in women if they had abnormal results on a 50-g glucose screening test and at least two abnormal plasma glucose values during a 100-g glucose tolerance test. Medical complications of pregnancy, pregnancy complications, and birth outcomes were compared between women with and without PCOS.
Results: Nine of 22 women with PCOS also had GDM diagnosis, compared with two of 66 controls (odds ratio [OR] 22.2; 95% confidence interval [CI] 3.8, 170.0), and these women exhibited increased plasma glucose values for all measurements except fasting. Five of 22 women with PCOS developed preeclampsia compared with one of 66 controls (OR 15.0; 95% CI 1.9, 121.5).
Conclusion: Women with PCOS are at increased risk of glucose intolerance and preeclampsia during pregnancy.
This article has been cited by other articles:
|
|
 |
|
  S. Hu, A. Leonard, A. Seifalian, and P. Hardiman Vascular dysfunction during pregnancy in women with polycystic ovary syndrome Hum. Reprod., June 1, 2007; 22(6): 1532 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E Kasim-Karakas, W. M Cunningham, and A. Tsodikov Relation of nutrients and hormones in polycystic ovary syndrome Am. J. Clinical Nutrition, March 1, 2007; 85(3): 688 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.M. Boomsma, M.J.C. Eijkemans, E.G. Hughes, G.H.A. Visser, B.C.J.M. Fauser, and N.S. Macklon A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome Hum. Reprod. Update, November 1, 2006; 12(6): 673 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Lo, S. L. Feigenbaum, G. J. Escobar, J. Yang, Y. M. Crites, and A. Ferrara Increased Prevalence of Gestational Diabetes Mellitus Among Women With Diagnosed Polycystic Ovary Syndrome: A population-based study Diabetes Care, August 1, 2006; 29(8): 1915 - 1917. [Full Text] [PDF]
|
|
|
|
 |
|
 A. H Balen, M. Dresner, E. M Scott, and J. O Drife Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ, February 25, 2006; 332(7539): 434 - 435. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Azziz, C. Marin, L. Hoq, E. Badamgarav, and P. Song Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4650 - 4658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Vanky, K.A. Salvesen, R. Heimstad, K.J. Fougner, P. Romundstad, and S.M. Carlsen Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study Hum. Reprod., August 1, 2004; 19(8): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J. Glueck, N. Goldenberg, P. Wang, M. Loftspring, and A. Sherman Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy Hum. Reprod., March 1, 2004; 19(3): 510 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wolf, J. Sauk, A. Shah, K. Vossen Smirnakis, R. Jimenez-Kimble, J. L. Ecker, and R. Thadhani Inflammation and Glucose Intolerance: A prospective study of gestational diabetes mellitus Diabetes Care, January 1, 2004; 27(1): 21 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Haakova, D. Cibula, K. Rezabek, M. Hill, M. Fanta, and J. Zivny Pregnancy outcome in women with PCOS and in controls matched by age and weight Hum. Reprod., July 1, 2003; 18(7): 1438 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mikola, V. Hiilesmaa, M. Halttunen, L. Suhonen, and A. Tiitinen Obstetric outcome in women with polycystic ovarian syndrome Hum. Reprod., February 1, 2001; 16(2): 226 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Polycystic Ovary Syndrome Predisposes to Gestational Diabetes Journal Watch Women's Health, September 1, 1999; 1999(901): 13 - 13. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
